Autolus Therapeutics appoints Ryan Richardson to its Board of Directors.

lunes, 1 de diciembre de 2025, 7:04 am ET1 min de lectura
AUTL--

Autolus Therapeutics has appointed Ryan Richardson to its Board of Directors. Richardson has over 20 years of experience in strategy and corporate development in the healthcare and investment banking industries. His appointment comes as Autolus enters a new phase of growth as a commercial-stage company, with the goal of maximizing the opportunity to expand obe-cel's reach in new indications.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios